Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.07
19.04.24
-
19.04.25
-10.90%
28.04.24

Could be very worthwhile Investment >20% year
michaelkr 
19.04.24 50%
sell
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.50
11.04.24
-
11.04.25
3.27%
14.04.24

Risky Investment
Global_Player 
11.04.24 50%
buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€9.75
07.04.24
€13.00
07.04.25
-17.28%
28.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
07.04.24 60%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.22
21.03.24
-
21.03.25
2.97%
29.03.24

Probably not worthwhile Investment
thomasw 
21.03.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.71
24.02.24
-
24.02.25
-5.26%
02.03.24

Could be worthwhile Investment >10% per year
Global_Player 
24.02.24 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€13.99
23.02.24
€15.00
23.02.25
4.93%
29.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Well known brand
Traumtanz 
23.02.24 50%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.55
22.02.24
-
22.02.25
4.52%
02.03.24

Very low/no dividend yield expected
Risky Investment
EBIT decline/stagnation expected
High valuation
kostojunior 
22.02.24 0%
sell
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.86
21.02.24
-
21.02.25
8.94%
02.03.24

Good culture
Probably not worthwhile Investment
No uniques
me8 
21.02.24 0%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
-
19.02.25
-24.30%
03.03.24

Probably not worthwhile Investment
thomasw 
19.02.24 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€13.70
17.02.24
€14.00
17.02.25
2.15%
23.02.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Well known brand
Traumtanz 
17.02.24 50%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.02
13.02.24
-
13.02.25
5.94%
17.02.24

Probably not worthwhile Investment
Vassago1 
13.02.24 50%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.72
05.02.24
-
05.02.25
24.42%
17.02.24

Very low/no dividend yield expected
Risky Investment
EBIT decline/stagnation expected
High valuation
kostojunior 
05.02.24 0%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€0.88
25.01.24
€1.30
25.01.25
143.18%
19.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
25.01.24 50%
buy
Uniqure B.V.

Start price
Target price
Perf. (%)
€5.16
21.01.24
-
21.01.25
-4.65%
03.02.24

Could be worthwhile Investment >10% per year
blaugold 
21.01.24 50%
buy
Ascendis Ph.sp.adr 1 Dk 1

Start price
Target price
Perf. (%)
€122.00
17.01.24
-
17.01.25
-2.46%
31.01.24

Saftman 
17.01.24 50%
buy
Uniqure B.V.

Start price
Target price
Perf. (%)
€5.79
07.01.24
-
07.01.25
-10.88%
20.01.24

Could be worthwhile Investment >10% per year
daimler1 
07.01.24 50%
sell
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.02
07.01.24
-
07.01.25
-16.47%
19.01.24

Probably not worthwhile Investment
Lokrim 
07.01.24 20%
buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€4.00
02.12.23
€5.00
31.10.25
-30.50%
10.12.23

Could be very worthwhile Investment >20% year
BiotechBee 
02.12.23 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€19.62
30.11.23
-
30.11.24
12.62%
08.12.23

Could be very worthwhile Investment >20% year
thomasw 
30.11.23 50%
buy
Blueprint Medicines Corp

Start price
Target price
Perf. (%)
€64.00
30.11.23
-
30.11.24
10.94%
31.01.24

Saftman 
30.11.23 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€17.95
28.11.23
€28.00
28.11.25
2.06%
11.12.23

Covacoro 
28.11.23 90%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€17.06
26.11.23
-
26.11.24
57.74%
09.12.23

Could be worthwhile Investment >10% per year
melinda 
26.11.23 10%
sell
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.20
28.10.23
€8.00
28.10.24
-4.07%
11.11.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
negative Cash Flow expected
nvestor 
28.10.23 50%
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€59.10
05.10.23
-
05.10.24
-8.93%
15.10.23

Could be worthwhile Investment >10% per year
Global_Player 
05.10.23 50%
sell
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€19.60
30.09.23
€9.00
30.09.24
11.22%
14.10.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
nvestor 
30.09.23 50%